Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 May;52(5):1200-6.
doi: 10.1172/jci107287.

Chemotactic factor inactivator in normal human serum

Chemotactic factor inactivator in normal human serum

J L Berenberg et al. J Clin Invest. 1973 May.

Abstract

Normal human serum contains an inactivator of chemotactic factors for neutrophilic leukocytes. The chemotactic factor inactivator (CF-I) remains soluble when serum is fractionated with ammonium sulfate (at 45% saturation), directly and irreversibly inactivates chemotactic factors, and it has a broad spectrum of activity as indicated by its inactivation of the chemotactic fragments of human C3 and C5 (third and fifth components of complement), C567, and the bacterial chemotactic factor derived from Escherichia coli. CF-I appears as a biphasic activity according to preparative techniques of sucrose density ultracentrifugation, electrophoresis, and gel filtration. Studies on the interaction of CF-I with the radiotagged C5 chemotactic fragment fail to reveal evidence for irreversible binding as the basis for inactivation. CF-I varies from the anaphylatoxin inactivator in several physical-chemical respects, but evidence does not permit a conclusive statement about the relationship of the two inactivators. CF-I may function as a regulator of inflammatory responses.

PubMed Disclaimer

References

    1. J Exp Med. 1966 Jan 1;123(1):33-54 - PubMed
    1. Immunology. 1966 Aug;11(2):141-53 - PubMed
    1. Adv Pharmacol. 1966;4:1-90 - PubMed
    1. J Exp Med. 1968 Feb 1;127(2):371-86 - PubMed
    1. Am J Pathol. 1968 Apr;52(4):725-36 - PubMed

Substances